151 related articles for article (PubMed ID: 4777551)
1. Studies on chloramphenicol. II. Possible determinants and progress of haemopoietic toxicity during chloramphenicol therapy.
O'Gorman Hughes DW
Med J Aust; 1973 Dec; 2(26):1142-6. PubMed ID: 4777551
[No Abstract] [Full Text] [Related]
2. Studies on chloramphenicol. 1. Assessment of haemopoietic toxicity.
Hughes DW
Med J Aust; 1968 Sep; 2(10):436-8. PubMed ID: 5681708
[No Abstract] [Full Text] [Related]
3. Blood dyscrasias attributed to chloramphenicol. A review of 576 published and unpublished cases.
Polak BC; Wesseling H; Schut D; Herxheimer A; Meyler L
Acta Med Scand; 1972 Nov; 192(5):409-14. PubMed ID: 5083381
[No Abstract] [Full Text] [Related]
4. Early hematological abnormalities associated with chloramphenicol therapy.
Beck EA; Buehler F; Armentrout SA; Lüdin H
Helv Med Acta; 1972; 36(4):295-306. PubMed ID: 4636280
[No Abstract] [Full Text] [Related]
5. Blood dyscrasias attributed to chloramphenicol: a review of 641 published and unpublished cases.
Polak BC; Wesseling H; Schut D; Herxheimer A
Postgrad Med J; 1974 Oct; 50 Suppl 5():123-6. PubMed ID: 4470805
[No Abstract] [Full Text] [Related]
6. Toxic effects of chloramphenicol. A survey of children treated in general practice.
Yodfat Y
Isr J Med Sci; 1969; 5(6):1184-7. PubMed ID: 5367443
[No Abstract] [Full Text] [Related]
7. Drug-induced blood dyscrasias.
Eisenhauer LA
Nurs Clin North Am; 1972 Dec; 7(4):799-808. PubMed ID: 4485732
[No Abstract] [Full Text] [Related]
8. [Iatrogenic hemopathies. Current aspects of drug effects on the formal elements of the blood].
Angela GC; Di Siena F
Minerva Med; 1970 Dec; 61(98):5659-76. PubMed ID: 4100810
[No Abstract] [Full Text] [Related]
9. [Chloramphenicol panmyelopathy in a child].
Juchum W
Wien Med Wochenschr; 1970 Jul; 120(30):536-42. PubMed ID: 5513642
[No Abstract] [Full Text] [Related]
10. Lack of evidence for systemic toxicity following topical chloramphenicol use.
Walker S; Diaper CJ; Bowman R; Sweeney G; Seal DV; Kirkness CM
Eye (Lond); 1998; 12 ( Pt 5)():875-9. PubMed ID: 10070527
[TBL] [Abstract][Full Text] [Related]
11. The clinical use of chloramphenicol.
Snyder MJ; Woodward TE
Med Clin North Am; 1970 Sep; 54(5):1187-97. PubMed ID: 4919149
[No Abstract] [Full Text] [Related]
12. [Drug-induced hematologic disorders in Japan].
Okubo H
Rinsho Ketsueki; 1974 Mar; 15(3):230-6. PubMed ID: 4136343
[No Abstract] [Full Text] [Related]
13. [Adverse effects of drugs on blood formation. I].
Libánský J
Cas Lek Cesk; 1971 Feb; 110(8):183-8. PubMed ID: 5545533
[No Abstract] [Full Text] [Related]
14. [Palmyelopathy following chloramphenicol (author's transl)].
Weingärtner L; Exadaktylos P
Klin Padiatr; 1974 Sep; 186(5):394-407. PubMed ID: 4475314
[No Abstract] [Full Text] [Related]
15. [Chloramphenicol therapy].
Blut; 1970 Feb; 20(2):125-6. PubMed ID: 5467350
[No Abstract] [Full Text] [Related]
16. [Effective activity of erythropoiesis: comparison of reticulocyte count and ferrokinetic measurement].
Rhyner K; Ganzoni AM
Schweiz Med Wochenschr; 1971 Dec; 101(49):1811-2. PubMed ID: 5140927
[No Abstract] [Full Text] [Related]
17. Oxyphenbutazone (Tanderil) and blood dyscrasia.
Brownlie BE; Strang PJ
N Z Med J; 1969 Feb; 69(441):77-9. PubMed ID: 5252205
[No Abstract] [Full Text] [Related]
18. Should chloramphenicol be used at all?
Med J Aust; 1971 Apr; 1(17):928-30. PubMed ID: 5576812
[No Abstract] [Full Text] [Related]
19. Data on the lack of a particular myelotoxicity of chloramphenicol in Israel.
Sheba C; Shani M
Haematol Lat; 1969; 12(3):539-42. PubMed ID: 5396825
[No Abstract] [Full Text] [Related]
20. Drug--induced bone marrow injury.
Yunis AA
Adv Intern Med; 1969; 15():357-76. PubMed ID: 4908623
[No Abstract] [Full Text] [Related]
[Next] [New Search]
